
Roche secures CE mark for acute dengue virus infection diagnostic test
Studies showed that the assay demonstrated a 94.90% sensitivity in polymerase chain reaction-confirmed positive samples.

Studies showed that the assay demonstrated a 94.90% sensitivity in polymerase chain reaction-confirmed positive samples.

SCOTTSDALE, Ariz., Oct. 30, 2025 /PRNewswire/ — In an exciting breakthrough for eye health, Barnet Dulaney Perkins, a leader in ophthalmic innovation, uses an advanced cataract surgery technique that delivers faster recovery, increased precision, and exceptional long-term results. The approach, which incorporates cutting-edge technology, revolutionizes how cataracts are treated, benefiting millions of patients worldwide.

Around a third of people over the age of 80 suffer from age-related macular degeneration (AMD), with an estimated 20 million Americans aged 40 and older currently living with AMD.

Tandem Diabetes Care (Nasdaq:TNDM) announced today that it launched its t:slim X2 insulin pump with the Abbott (NYSE:ABT) FreeStyle Libre 3 Plus CGM.

Diagnosing heart failure in women can be particularly challenging. New research on biomarkers may lead to more accurate diagnoses for heart failure, in both women and men.

Australian scientists have developed a biosensor that can rapidly detect the heart failure biomarker S100A7 in saliva, offering a simple, noninvasive way to identify the disease. The breakthrough, published in Biosensors and Bioelectronics: X, could make heart failure screening more accessible, especially in remote and under-resourced communities.

The breakdown of myelin, the insulating layer around brain cells that supports brain function, is prevalent in a range of neurodegenerative diseases, aging and because of various forms of trauma.

Scientists have found a way to pick the best pacemaker for each patient, potentially making them last years longer.

Barely an hour after being wheeled into a clinical space at Oregon Health & Science University on Aug. 27, an Arkansas woman emerged with vastly improved symptoms of the Parkinson’s disease that had plagued her for the past seven years.

Patients with weak heart function who receive stem cell therapy shortly after a heart attack are at lower risk of developing heart failure and related hospital stays compared with standard care, finds a clinical trial published by The BMJ today.